Stem Cell Agency Board Governing Board Meeting 6/22-23/10

Day 1
Jun 22, 2010
Main Location: 

Sheraton San Diego
Marina Tower, Harbor Island I room
1380 Harbor Island Drive
San Diego, CA 92101

Additional Locations: 
City of Hope 1500 E. Duarte Road Duarte, California 91010
Call-in Information: 
To access the live event or archive, use this URL: http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 161380. Then click Go. (no password)
Day 2
Jun 23, 2010
Main Location: 

Sheraton San Diego
Marina Tower, Harbor Island I room
1380 Harbor Island Drive
San Diego, CA 92101

Additional Locations: 
City of Hope 1500 E. Duarte Road Duarte, California 91010
1150 22nd Street, N.W., Washington, D.C. 20037
5555 W Las Positas Blvd, Pleasanton, California 94588
7257 Beverly Blvd., Suite #218 Los Angeles, California 90036
Call-in Information: 
To access the live event or archive, use this URL: http://205.144.147.162/cgi-bin/confCast Enter Conference ID# 161382. Then click Go. (no password)

Stem Cell Agency Governing Board Meeting

 

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS’ OVERSIGHT COMMITTEE
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

1. Call to Order.

2. Pledge of Allegiance.

3. Roll Call.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

REPORTS

4. Chairman’s Report.

5. President’s Report.


CONSENT CALENDAR

6. Consideration of minutes from 4/28-9/10 Board Meeting.

CLOSED SESSION

7. Discussion of Personnel [Evaluation of Board Chair] (Government Code section 11126, subdivision (a); Health & Safety Code section 125290.30(d) (3) (D)).

Public report of any action taken, if necessary, during closed session.


ACTION ITEMS

8. Consideration of recommendations from Grants Working Group regarding applications submitted in response to RFA 09-03 CIRM Stem Cell Transplantation Immunology Research Awards.

A) Extraordinary Petition for Application RM1-01705
B) Extraordinary Petition for Application RM1-01717
C) Extraordinary Petition for Application RM1-01721
D) Extraordinary Petition for Application RM1-01731
E) Extraordinary Petition for Application RM1-01745
F)  Extraordinary Petition for Application RM1-01716 LATE
G) Extraordinary Petition for Application RM1-01710 LATE
H) Extraordinary Petition for Application RM1-01742 LATE
I) Extraordinary Petition for Application RM1-01733 LATE

CLOSED SESSION

9. Discussion of confidential intellectual property or work product and prepublication, and confidential scientific research or data relating to applications for CIRM Stem Cell Transplantation Immunology Research Awards. (Health & Safety Code 125290.30(d) (3) (B) and (C)).

Public report of any action taken, if necessary, during closed session.


ACTION ITEMS

10. Consideration of CIRM budget for fiscal year 2010-2011.

A) CIRM Proposed 2010-2011 Operating Budget, Table 1A
B) CIRM Proposed 2010-2011 Budget, Table 2A: Science Office
C) CIRM Proposed 2010-2011 Budget, Table 2B: Office of Administration
D) CIRM Proposed 2010-2011 Budget, Table 2C: Office of the President
E) CIRM Proposed 2010-2010 Budget, Table 2D: Office of the Chair
F) CIRM Proposed 2010-2011 Budget, Table 3: Contract Services
G) CIRM Proposed 2010-2011 Budget, Table 4: IT
H) CIRM Proposed 2010-2011 Budget, Table 5: Expense History
I) CIRM Proposed 2010-2011 Budget, Table 6: Expense History Summary
J) CIRM Proposed 2010-2011 Budget, Table 7: Projected Expenses
K) CIRM Proposed 2010-2011 Budget Notes

11. Consideration of proposed new member for Standards Working Group.

12. Consideration of proposed new scientific members for Grants Working Group.

13. Consideration of concept proposal for Basic Biology III Awards.

14. Consideration of technical amendment to Compensation Program.

ADDENDUM

15. Consideration of update regarding SB 1064 (Alquist)


DISCUSSION ITEMS

16. Discussion of Development Candidate Portfolio Review.

17. Review of Strategic Financial Projections.
b. Slide presentation

18. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov .
 

© 2013 California Institute for Regenerative Medicine